ArticleFrontiers in pediatrics2024

Ustekinumab in pediatric patients with Crohn's disease: safety, and efficacy results from a multicenter retrospective study in China.

Ping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.